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Auto control modeAbstract Background: Recently a concept of target controlled inhalational anesthesia (TCA) is
introduced in which the fresh gas ﬂow and its composition are automatically delivered to the
patients with the least possible ﬂow. The aim of this study is to compare safety, consumption
and cost of both sevoﬂurane and desﬂurane when delivered by target controlled anesthesia
(TCA) using fully closed circuit conditions.
Patient and method: After approval of the hospital review board and obtaining parental informed
consent, 60 pediatric patients aged 2–12 were selected. The patients were classiﬁed into two groups
according to the anesthetic used S Group (n= 30) in which sevoﬂurane D Group (n= 30): in
which desﬂurane was used. Both were delivered by auto control mode of Zeus machine. Anesthetic
agent and O2 consumption, cost and number of adjustments were assessed. Blood samples were
obtained preoperatively and at 24, 48 and 72 h after the end of surgery for measuring serum creat-
inine, BUN, AST and ALT. Twenty-four hour urine samples were collected for 3 consecutive days
to measure glucose, microprotein and creatinine for the estimation of creatinine clearance.
Results: This study revealed that sevoﬂurane group had a lower O2, anesthetic consumption and
cost than desﬂurane group. Also both groups had higher levels of serum urea and creatinine
together with urinary microproteins and glucose in the ﬁrst three post-operative days compared
to preoperative values which indicates minor tubular insult. However there was no statistically sig-
niﬁcant difference between the two groups.
Conclusion: Sevoﬂurane is as safe as desﬂurane when delivered by auto control mode of Zeus
machine with decreased anesthetic consumption and cost.
ª 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists.D license.
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Low ﬂow anesthesia has various advantages which include
decreased consumption of medical gases and volatile anesthet-
ics with its economic impact, reduction of anesthetic gas loss
into the atmosphere with its environmental impact and ﬁnally
conservation of temperature and humidity of the airway [1].
More recently a concept of target controlled inhalational
anesthesia (TCA) is introduced in which the fresh gas ﬂow
and its composition are automatically delivered to the patients
with the least possible ﬂow. Theoretically target controlled
anesthesia has many advantages in inhalational anesthesia
practice which include decreased time to achieve a desired alve-
olar anesthetic gas concentration together with decreased over-
shoots and ﬂuctuation of anesthetic agent. Another advantage
is that the need for repeated anesthetic adjustments is mark-
edly minimized decreasing the work of anesthetist. [2].
Modern anesthesia machines that implemented the target
controlled concept has an auto control mode that deliver tar-
get controlled anesthesia with a fully closed circuit through
blower-driven ventilator, an electronically-controlled gas and
vapor delivery system and a servo-controlled valve system [3].
The last generations of halogenated anesthetics (desﬂurane
and sevoﬂurane) have certain pharmacokinetic and pharmaco-
dynamic properties which have been greatly magniﬁed in min-
imal ﬂow states. These anesthetic agents have low potency and
low solubility in tissues, which fastens equilibration between
concentrations of the alveoli and the brain. This makes these
agents ideal for minimal ﬂow and closed circuit conditions;
hence, their Minimum Alveolar Concentration (MAC) in the
inspiratory mixture is easily reached [4].
Despite being synthesized before the 1970s, one of the
major barriers to their use is the high cost together with greater
amount of agent required. This is evident in desﬂurane which
has the highest MAC known among all anesthetic agents
increasing its consumption and overall cost [4].
The side effects of accumulated volatile substances as an
outcome of metabolism of sevoﬂurane are another aspect to
be considered and may add to barriers of its use in minimal
ﬂow conditions [5].
The aim of this study is to compare safety, consumption
and cost of both sevoﬂurane and desﬂurane when delivered
by auto-control mode of Zeus machine that deliver target con-
trolled anesthesia (TCA) using fully closed circuit conditions.
2. Patients and methods
After approval of the hospital review board and obtaining
parental informed consent, 60 pediatric patients aged 2–12
and ASA status I–II with normal liver and kidney function
scheduled for procedures longer than two hours duration in
children’s cancer hospital of Egypt were included in this study.
2.1. Anesthetic management
After arrival of the patients in the holding area, I.V cannula
was inserted; midazolam 0.2 mg kg1 and atropine
0.02 mg kg1 were administered intravenously for anxiolysis.
Patients then were transferred into the operating theatre and
the non invasive monitoring including electrocardiogram,non-invasive blood pressure, pulse oximetry, axillary tempera-
ture and bispectral index (BIS) was used to estimate hypnosis.
All patients had warming blanket to maintain a body temper-
ature between 34 and 36 C throughout surgery. Anesthesia
was induced with propofol (2.5 mg kg1), atracurium
(0.5 mg kg1), and fentanyl (2 lg kg1). After endo-tracheal
intubation, the patient’s lungs were mechanically ventilated
with volume-controlled mode in order to maintain an end-tidal
CO2 between 30 and 36 mmHg, with O2/air, with an inspired
O2 concentration of 50%. The anesthesia machine used
(Zeus, Draeger, Luebeck, Germany) utilizing target con-
trolled anesthesia (TCA) through the autocontol mode.2.2. Study settings
The patients were classiﬁed into two groups according to the
anesthetic used:
S Group (n= 30): in which sevoﬂurane was delivered by
auto control mode of Zeus machine.
D Group (n= 30): in which desﬂurane was delivered by
auto control mode of Zeus machine.
In both groups, during maintenance, the administered end
tidal concentration of agent used was readjusted in order to
maintain the BIS value between 40 and 60 units. Adequate
neuromuscular blockade was achieved using atracurium
boluses at 0.15 mg kg1 every 20 min.
During skin closure, anesthetic was discontinued and
the patient received 100% O2. At 25% recovery of the ﬁrst
response to train-of-four stimulation, neuromuscular blockade
was reversed by neostigmine (4 lg kg1) and atropine
(15 lg kg1).
2.4. Measured and recorded parameters
1. Anesthetic agent and O2 consumption, cost and number of
adjustments:
Sevoﬂurane, desﬂurane and O2 consumption were obtained
and recorded from the integrated Zeus delivery system and cal-
culated as per hour consumption. Cost is calculated as per
hour cost by Egyptian pound. Also the number of adjustments
needed to maintain the BIS value between 40 and 60 units were
recorded.
2. The laboratory variables:
 Renal function
A. Standard renal biomarkers
Blood samples were obtained preoperatively and at 24, 48
and 72 h after the end of surgery for measuring serum creati-
nine and BUN. Normal values are deﬁned by the commercial
laboratory. Results are expressed in conventional units.
B. Speciﬁc renal biomarkers
Twenty-four hours urine samples were collected for 3 con-
secutive days to measure glucose, protein in urine as sensitive
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sured in urine for estimation of creatinine clearance.
 Hepatic function
Blood samples were obtained preoperatively and at 24, 48
and 72 h after the end of surgery for measuring aspartate ami-
notransferase [AST] and alanine aminotransferase [ALT] using
automated chemistry system.
2.5. Statistical analysis
Data collected were revised, coded, tabulated and introduced
to a personal computer (PC) for statistical analysis. Qualitative
data presented in the form of frequency tables (number and
percent). Quantitative data presented in the form of means
and SD.
Normality of distribution of variables was tested using one
sample Kolmogorov Smirnov test. Differences between groups
were assessed using the Student’s t test for normally
distributed data and Mann Whitney U test for non-normal
distributed data. The chi-square test was used to compare
the differences of categorical variables between groups.
Paired-samples t test for normal and Wilcoxon test for non-
normal distributed data were used to analyze changes from
preanesthesia to postanesthesia at 24, 48, and 72 h. SPSS (Sta-
tistical Package for Social Science) version 16 was used for sta-
tistical analysis. A p value < 0.05 was considered statistically
signiﬁcant.
3. Results
As regards patients’ demographics, mean age, weight, sex,
duration of surgery and MAC-hour results were comparable
in both groups. There was no statistically signiﬁcant difference
between the groups (Table 1).Table 1 Patient’s demographic data in the studied groups.
Variables S group
n= 30
Age (years) 7.5 (3.9–10.8)
Male/female 16/14
Weight (kg) 23 (15.1–29.5)
Duration of anesthesia (h) 5.3 ± 1.6
Data are presented as mean ± SD, median (range) and ratio.
Table 2 O2 anesthetic consumption, cost and number of adjustmen
Variables S group
n= 30
O2 consumption (L/h) 15.65 ± 4.9
Agent consumption (ml/h) 3.1 ± 1.3
Cost (Egyptian pound/h) 13.4 ± 4.6
Number of adjustments 3.65 ± 0.75
Results are represented as mean ± SD.O2 and anesthetic agent consumption, cost and number of
adjustments were signiﬁcantly lower in S group than in D
group (Table 2).
In both groups serum creatinine levels postanesthesia were
signiﬁcantly higher than preanesthetic values at all assessment
time points. In S group, preanesthetic creatinine value was
0.29 ± 0.13 vs. 0.52 ± 0.14, 0.47 ± 0.13 and 0.44 ± 0.14 at
24, 48, and 72 h, respectively, whereas in D group, preanesthet-
ic creatinine value was 0.26 ± 0.12 vs 0.48 ± 0.09, 0.46 ± 0.11
0.44 ± 0.09 at 24, 48, and 72 h, respectively. However, there
was no signiﬁcant difference between both groups regarding
creatinine level all over the study period. Also serum BUN val-
ues postanesthesia were signiﬁcantly higher than pre-anesthetic
values in both groups at all assessment time points. In S group,
preanesthetic value was 6.2 ± 2.9, vs 7.4 ± 2.6, 7.2 ± 2.7 and
8.4 ± 3.1 at 24, 48, and 72 h, respectively, while in D group,
preanesthetic value was 4.7 ± 2.3 vs 6.3 ± 2.4, 6.9 ± 2.6
and 8.4 ± 2.1 at 24, 48, and 72 h, respectively. However, there
were no signiﬁcant differences between both groups regarding
BUN level at assessment time points of the study period.
There were no statistically signiﬁcant differences between
both groups regarding twenty-four hour creatinine clearance
level at any time throughout the study period. In S group, pre-
anesthetic value was 127.1 ± 37.4 vs 144.2 ± 25.6,
141.2 ± 39.1 and 140.2 ± 46.1 at 24, 48, and 72 h, respec-
tively,) and in D group, preanethetic value was 143.8 ± 22.4
vs 135.4 ± 23.8, 137.1 ± 19.46 and 147.3 ± 15.6 at 24, 48,
and 72 h, respectively.
Twenty-four hour urinary protein and glucose levels were
signiﬁcantly higher from the pre-anesthetic values in both
groups at 24, 48, 72 h (Tables 3 and 4). However, there were
no statistically signiﬁcant differences between both groups
regarding twenty-four hour urinary proteins (The 2 groups
comparison had p values of: 0.09, 0.13, 0.06 at 24, 48, 72 h,
respectively) (Table 3). Also glucose levels showed no signiﬁ-
cant differences at all assessment time points through the studyD group P value
n= 30
9 (6.6–12) 0.13
14/16 0.20
21 (18–38.5) 0.66
5.1 ± 2.97 0.81
ts among the studied groups.
D group P value
n= 30
117.4 ± 30.6 <0.001
16.4 ± 7.1 <0.001
33.6 ± 6.7 <0.001
5.45 ± 1.9 <0.001
Table 3 Twenty-four hour urinary protein level in both
studied groups.
S group D group
n= 30 n= 30
Pre-anesthesia 32(15–86) 73(22–108)
24 h 65(40.5–187.5)* 189.5(44.75–262.5)*
48 h 64(28.5–205)* 260(27.25–406.5)*
72 h 52(26.3–172.8)** 173(35–227.5)*
Data are presented as median (inter-quartile range).
Normal range of urinary proteins in 24 h = 0–150 mg/day.
* P< 0.001 in comparison with pre-anesthetic level.
** P= 0.01 in comparison with pre-anesthetic level.
Table 4 Twenty-four hour urinary glucose level in both
studied groups.
S group D group
n= 30 n= 30
Pre-anesthesia 5(0–14.25) 12.5(0–20)
24 h 21(12.25–52.25)* 44(28–52.8)*
48 h 19.5(14.25–36.5)* 33(14.3–60)*
72 h 14.5(10.5–22) 19(15–39.5)
Data are presented as median (inter-quartile range).
P< 0.001 in comparison with pre-anesthetic level.
Normal range of urinary glucose = 0–20 gm/day.
 P= 0.004 in comparison with pre-anesthetic level.
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respectively (Table 4).
Serum AST and ALT levels were not signiﬁcantly different
from the pre-anesthetic values in either group all over the
study period. Also, there were no statistically signiﬁcant differ-
ences between both groups regarding serum AST and ALT
values at any time through the study period (Fig. 1).
4. Discussion
This study revealed that sevoﬂurane group had a lower O2,
anesthetic consumption and cost than desﬂurane group. Also,
both groups had higher levels of serum urea and creatinine
together with urinary microproteins and glucose in the ﬁrst 3
post operative days compared to preoperative values whichFigure 1 Serum AST and ALT in groindicates minor tubular insult. However, there was no statisti-
cally signiﬁcant difference between the two groups. It is worthy
to mention that by the 3rd day all values were within normal
values in both groups.
Soﬁe et al. compared desﬂurane consumption during auto-
control mode of Zeus machine and conventional anesthesia
machine with low fresh gas ﬂow and concluded that desﬂurane
consumption was higher in auto control mode [6]. Another
study for cost analysis of two anesthetic machines: ‘‘primus’’
and ‘‘zeus’’ showed that the consumption of sevoﬂurane and
isoﬂurane is also higher in auto control mode [7], and this
was contrary to a study by Lortat et al. who assessed clinical
and pharmaco-economic beneﬁts of TCA showed decreased
desﬂurane consumption in auto control mode [8].
In the present study, the higher consumption of desﬂurane
may be due to the higher MAC that needs more time by the
machine to reach the target expired setting of desﬂurane with
more oxygen and desﬂurane consumption. Also, because of
the automatic control of fresh gas and volatile agent ﬂow,
any change in the targeted concentration of volatile agent in
the circle system was achieved using maximum fresh gas ﬂow
rates of oxygen for rapid equilibration. This means that with
each adjustment to the desired inspired expired anesthetic
agent, the circle system became more toward higher ﬂows as
open breathing circuits with higher oxygen and agent con-
sumption [7]. In our study, higher number of adjustments
was reported with desﬂurane that also may add to higher des-
ﬂurane consumption.
Lately in the last century, there was controversy about
safety of low ﬂow sevoﬂurane due to accumulation of toxic
metabolite in the anesthetic circuit, however many literatures
supports its safety. A retrospective study evaluated pooled
renal laboratory data from 22 different clinical trials that com-
pared sevoﬂurane with isoﬂurane, enﬂurane, or propofol. The
trials examined postoperative changes in serum creatinine and
blood urea nitrogen levels from a total of 3436 adult surgical
patients. The incidences of increased serum creatinine and
blood urea nitrogen concentrations were similar among
patients administered sevoﬂurane and those administered con-
trol drugs. Additionally, no trends speciﬁc to sevoﬂurane were
observed as regard to postoperative serum creatinine concen-
tration with the fresh gas ﬂow rate and concurrent treatment
with nephrotoxic antibiotics, or type of carbon dioxide absor-
bent [9].
In another study, 17 patients with stable renal insufﬁciency
were anesthetized with sevoﬂurane or isoﬂurane at a total ﬂowups of patients under investigation.
Sevoﬂurane and desﬂurane in target controlled anesthesia 329of 1 L/min. Renal function was assessed with serum creatinine
and blood urea nitrogen. The results showed no signiﬁcant
changes in blood urea nitrogen levels, serum creatinine concen-
trations, or creatinine clearance after anesthesia within each
group [10]. Even in cirrhotic patients who are prone to renal
dysfunction after anesthesia, [11] concluded that sevoﬂurane
did not seem to impair post-operative renal function.
Also recently, Sahin and coworkers [12] evaluated the effect
of moderate duration low-ﬂow sevoﬂurane on renal and hepa-
tic functions in 80 patients, with an operation time of 120–
240 min. They reported similar results to the current study.
They found that postoperative serum BUN, creatinine and
urine glucose were signiﬁcantly higher from the preoperative
values. However, all values were within the normal range.
In 80 children aged 5–15 years, no signiﬁcant effect on renal
and hepatic functions was found after low ﬂow sevoﬂurane
anesthesia [13]. Many factors common to anesthesia and surgi-
cal procedures have been concerned in the cause of renal dys-
function/injury. Antibiotics, surgical stress, preexisting renal
disease, intraoperative blood pressure, site of surgery, and
anesthetics are some of the suggested factors.
It is suggested in the current study that an additional factor
which adds to sevoﬂurane safety with auto control mode of
Zeus is the automatic ﬂushing that occurs with each anesthetic
agent adjustment increasing the ﬂow toward open circuit that
may wash any toxic metabolite in the circuit.
In conclusion, sevoﬂurane is as safe as desﬂurane when
delivered by auto control mode of Zeus machine with
decreased anesthetic consumption and cost.Conﬂict of interest
None declared.
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